SCHEMBL19265705

SCHEMBL19265705

CCOC(=O)C1=Cc2cc(-c3ccc(C(=O)OCC)cc3)ccc2NC(N=NN)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDFT1 P37268 1/20 0.38
▸ STS P08842 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ RAB9A P51151 1/20 0.35
▸ NOS3 P29474 2/20 0.35
▸ NOS1 P29475 2/20 0.35
▸ NOS2 P35228 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MASP2 O00187 1/20 0.35
▸ GAPDH P04406 1/20 0.35
▸ HSPA1A P0DMV8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19265523 0.93 TLR8 (0.35) LMNAKDM4EHPGDMEN1KMT2A
SCHEMBL19265546 0.93 TLR8 (0.33) FDFT1STSCYP1A2CYP3A4RAB9A
SCHEMBL19265638 0.92 KDM4E (0.36) KDM4EPOLBALDH1A1CA1CA2
SCHEMBL19265526 0.92 TLR8 (0.40) CYP1A2RAB9AKDM4EHPGDMEN1
SCHEMBL19265644 0.90 MMP2 (0.41) HPGDALDH1A1HSD17B10SMN1; SMN2TLR8
SCHEMBL19265449 0.89 TLR8 (0.41) LMNAKDM4EHPGDMEN1KMT2A
SCHEMBL19265650 0.86 KDM4E (0.39) CYP1A2CYP3A4RAB9AKDM4EHPGD
SCHEMBL18771933 0.85 TLR8 (0.34) STSCYP1A2CYP3A4RAB9AKDM4E
SCHEMBL18772002 0.84 HPGD (0.37) LMNARAB9AHPGDMEN1POLB
SCHEMBL19265647 0.84 PRKCZ (0.37) MEN1KMT2AL3MBTL1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3208263-A1 SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS VentiRx Pharmaceuticals, Inc. (US) 2017-08-23 — — EP disclosed
Send feedback